Authors:
JOINER KA
POWDERLY WG
BLASER MJ
KLEMPNER MS
LOCKSLEY RM
MANDELL GL
PREHEIM LC
REMINGTON JS
SLAMA TG
STEIGBIGEL NH
BARTLETT JG
Citation: Ka. Joiner et al., FELLOWSHIP TRAINING IN INFECTIOUS-DISEASES - A REPORT FROM THE REGIONAL AND NATIONAL MEETINGS OF INFECTIOUS-DISEASES DIVISION CHIEFS AND PROGRAM DIRECTORS, Clinical infectious diseases, 26(5), 1998, pp. 1060-1065
Authors:
LOPEZ FA
CROWLEY RS
WASTILA L
VALANTINE HA
REMINGTON JS
Citation: Fa. Lopez et al., SCEDOSPORIUM APIOSPERMUM (PSEUDALLESCHERIA-BOYDII) INFECTION IN A HEART-TRANSPLANT RECIPIENT - A CASE OF MISTAKEN IDENTITY, The Journal of heart and lung transplantation, 17(3), 1998, pp. 321-324
Authors:
SUZUKI Y
LIESENFELD O
KANG H
NGUYEN TA
PARKHE CV
SHER A
REMINGTON JS
Citation: Y. Suzuki et al., A CRITICAL ROLE FOR IFN-GAMMA, TNF-ALPHA AND NITRIC-OXIDE (NO) IN GENETIC SUSCEPTIBILITY OF MICE TO PERORAL INFECTION WITH TOXOPLASMA-GONDII, The FASEB journal, 12(4), 1998, pp. 3322-3322
Citation: Aa. Khan et al., EFFECT OF TROVAFLOXACIN ON PRODUCTION OF CYTOKINES BY HUMAN MONOCYTES, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1713-1717
Authors:
SUBAUSTE CS
FUH F
MALEFYT RD
REMINGTON JS
Citation: Cs. Subauste et al., ALPHA-BETA-T-CELL RESPONSE TO TOXOPLASMA-GONDII IN PREVIOUSLY UNEXPOSED INDIVIDUALS, The Journal of immunology, 160(7), 1998, pp. 3403-3411
Authors:
YADLAPATI S
DORSKY D
REMINGTON JS
EDWARDS RL
FEINGOLD JM
TUTSCHKA PJ
BILGRAMI S
Citation: S. Yadlapati et al., OCULAR TOXOPLASMOSIS AFTER AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Clinical infectious diseases, 25(5), 1997, pp. 1255-1256
Authors:
MONTOYA JG
JORDAN R
LINGAMNENI S
BERRY GJ
REMINGTON JS
Citation: Jg. Montoya et al., TOXOPLASMIC MYOCARDITIS AND POLYMYOSITIS IN PATIENTS WITH ACUTE ACQUIRED TOXOPLASMOSIS DIAGNOSED DURING LIFE, Clinical infectious diseases, 24(4), 1997, pp. 676-683
Authors:
WILSON M
REMINGTON JS
CLAVET C
VARNEY G
PRESS C
WARE D
HERMAN CL
SHIVELY RG
SIMMS TE
HANSEN S
GAFFEY CM
NUTTER CD
LANGONE JJ
MCCRACKEN J
STAPLES B
Citation: M. Wilson et al., EVALUATION OF 6 COMMERCIAL KITS FOR DETECTION OF HUMAN-IMMUNOGLOBULIN-M ANTIBODIES TO TOXOPLASMA-GONDII, Journal of clinical microbiology, 35(12), 1997, pp. 3112-3115
Authors:
LIESENFELD O
PRESS C
MONTOYA JG
GILL R
ISAACRENTON JL
HEDMAN K
REMINGTON JS
Citation: O. Liesenfeld et al., FALSE-POSITIVE RESULTS IN IMMUNOGLOBULIN-M (IGM) TOXOPLASMA ANTIBODY TESTS AND IMPORTANCE OF CONFIRMATORY TESTING - THE PLATELIA TOXO IGM TEST, Journal of clinical microbiology, 35(1), 1997, pp. 174-178
Authors:
KHAN AA
SLIFER T
ARAUJO FG
POLZER RJ
REMINGTON JS
Citation: Aa. Khan et al., ACTIVITY OF TROVAFLOXACIN IN COMBINATION WITH OTHER DRUGS FOR TREATMENT OF ACUTE MURINE TOXOPLASMOSIS, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 893-897
Authors:
ARAUJO FG
KHAN AA
SLIFER TL
BRYSKIER A
REMINGTON JS
Citation: Fg. Araujo et al., THE KETOLIDE ANTIBIOTICS HMR-3647 AND HMR-3004 ARE ACTIVE AGAINST TOXOPLASMA-GONDII IN-VITRO AND IN MURINE MODELS OF INFECTION, Antimicrobial agents and chemotherapy, 41(10), 1997, pp. 2137-2140
Citation: Fg. Araujo et al., TREATMENT WITH INTERLEUKIN-12 IN COMBINATION WITH ATOVAQUONE OR CLINDAMYCIN SIGNIFICANTLY INCREASES SURVIVAL OF MICE WITH ACUTE TOXOPLASMOSIS, Antimicrobial agents and chemotherapy, 41(1), 1997, pp. 188-190
Authors:
HUNTER CA
ELLISNEYER L
GABRIEL KE
KENNEDY MK
GRABSTEIN KH
LINSLEY PS
REMINGTON JS
Citation: Ca. Hunter et al., THE ROLE OF THE CD28 B7 INTERACTION IN THE REGULATION OF NK CELL RESPONSES DURING INFECTION WITH TOXOPLASMA-GONDII/, The Journal of immunology, 158(5), 1997, pp. 2285-2293
Authors:
SUZUKI Y
RANI S
LIESENFELD O
KOJIMA T
LIM S
NGUYEN TA
DALRYMPLE SA
MURRAY R
REMINGTON JS
Citation: Y. Suzuki et al., IMPAIRED RESISTANCE TO THE DEVELOPMENT OF TOXOPLASMIC ENCEPHALITIS ININTERLEUKIN-6-DEFICIENT MICE, Infection and immunity, 65(6), 1997, pp. 2339-2345
Authors:
NEYER LE
GRUNIG G
FORT M
REMINGTON JS
RENNICK D
HUNTER CA
Citation: Le. Neyer et al., ROLE OF INTERLEUKIN-10 IN REGULATION OF T-CELL-DEPENDENT AND T-CELL-INDEPENDENT MECHANISMS OF RESISTANCE TO TOXOPLASMA-GONDII, Infection and immunity, 65(5), 1997, pp. 1675-1682
Authors:
MINKOFF H
REMINGTON JS
HOLMAN S
RAMIREZ R
GOODWIN S
LANDESMAN S
Citation: H. Minkoff et al., VERTICAL TRANSMISSION OF TOXOPLASMA BY HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN, American journal of obstetrics and gynecology, 176(3), 1997, pp. 555-559
Authors:
LIESENFELD O
KOSEK J
REMINGTON JS
SUZUKI Y
Citation: O. Liesenfeld et al., ASSOCIATION OF CD4(-CELL-DEPENDENT, IFN-GAMMA-MEDIATED NECROSIS OF THE SMALL-INTESTINE WITH GENETIC SUSCEPTIBILITY OF MICE TO PERORAL INFECTION WITH TOXOPLASMA-GONDII() T), Molecular biology of the cell, 7, 1996, pp. 895-895
Citation: Jg. Montoya et Js. Remington, TOXOPLASMIC CHORIORETINITIS IN THE SETTING OF ACUTE ACQUIRED TOXOPLASMOSIS, Clinical infectious diseases, 23(2), 1996, pp. 277-282
Citation: Fg. Araujo et al., USE OF RIFABUTIN IN COMBINATION WITH ATOVAQUONE, CLINDAMYCIN, PYRIMETHAMINE, OR SULFADIAZINE FOR TREATMENT OF TOXOPLASMIC ENCEPHALITIS IN MICE, European journal of clinical microbiology & infectious diseases, 15(5), 1996, pp. 394-397
Authors:
LIESENFELD O
PRESS C
FLANDERS R
RAMIREZ R
REMINGTON JS
Citation: O. Liesenfeld et al., STUDY OF ABBOTT-TOXO-IMX SYSTEM FOR DETECTION OF IMMUNOGLOBULIN-G ANDIMMUNOGLOBULIN-M TOXOPLASMA ANTIBODIES - VALUE OF CONFIRMATORY TESTING FOR DIAGNOSIS OF ACUTE TOXOPLASMOSIS, Journal of clinical microbiology, 34(10), 1996, pp. 2526-2530
Citation: Fg. Araujo et al., RIFAPENTINE IS ACTIVE IN-VITRO AND IN-VIVO AGAINST TOXOPLASMA-GONDII, Antimicrobial agents and chemotherapy, 40(6), 1996, pp. 1335-1337
Authors:
PATEL DV
HOLFELS EM
VOGEL NP
BOYER KM
METS MB
SWISHER CN
ROIZEN NJM
STEIN LK
STEIN MA
HOPKINS J
WITHERS SE
MACK DG
LUCIANO RA
MEIER P
REMINGTON JS
MCLEOD RL
Citation: Dv. Patel et al., RESOLUTION OF INTRACRANIAL CALCIFICATIONS IN INFANTS WITH TREATED CONGENITAL TOXOPLASMOSIS, Radiology, 199(2), 1996, pp. 433-440